Logo for Vivoryon Therapeutics N.V.

Vivoryon Therapeutics Investor Relations Material

Latest events

Logo for Vivoryon Therapeutics N.V.

H2 2024

Vivoryon Therapeutics
Logo for Vivoryon Therapeutics

H2 2024

29 Apr, 2025
Logo for Vivoryon Therapeutics

Status Update

18 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Vivoryon Therapeutics N.V.

Access all reports
Vivoryon Therapeutics N.V., previously known as Probiodrug, is a Germany-based clinical-stage biopharmaceutical company. It specializes in the discovery and development of therapies for patients suffering from age-related diseases, with a primary focus on Alzheimer’s disease and cancer immune checkpoint inhibition. The company leverages its expertise in understanding post-translational modifications to develop small molecule medications that modulate the activity and stability of proteins altered in disease settings. The company is headquartered in Halle (Saale), Germany, and its shares are listed on the Euronext Amsterdam.